Loading
Journal of Diabetes and Clinical Research
ISSN: 2689-2839
Latest Articles
Ephrin B1 Regulates Inflammatory Pathways in Retinal Müller Cells
Li Liu , Youde Jiang , Mohamed Al-Shabrawey , Jena J. Steinle
The role of inflammation has been accepted as a factor in the complications of diabetic retinopathy. Discovery of the upstream regulation of these inflammatory factors has remained a challenge. In this study, we explored the actions of ephrin B1 in retinal Müller cells and their actions on inflammatory proteins. We used diabetic human and mouse samples, as well as Müller cells in culture to measure ephrin B1 in Müller cells.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p1-7 | DOI: 10.33696/diabetes.6.056
A Clinical Case Report: Utility of Amniotic Membrane in Treating a Geriatric Diabetic Patient with a Chronic Pressure Ulcer
Alison L. Ingraldi , Kristina Galbreath , Denise Jones , Darlene Lee , Aaron J. Tabor
Chronic wound closure is the inability for a wound to progress through the standard wound healing stages and timeframe, often stalling during the inflammatory stage. This paper presents a two-year open wound endured by a Native American patient of geriatric age and uncontrolled type II diabetes based on elevated A1c levels. Multiple therapeutic modalities had been attempted to close the wound, without improvement.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p8-14 | DOI: 10.33696/diabetes.6.057
Use of Sodium-Glucose Co-transporter-2 Inhibitors after Acute Myocardial Infarction
Nasser Mikhail
Whether sodium-glucose co-transporters-2 (SGLT2) inhibitors have beneficial effects on cardiovascular (CV) events and mortality if given within few days from acute myocardial infarction (AMI) is unknown. The DAPA-MI trial (n= 4,107) is the only available study designed to evaluate the impact of administration of dapagliflozin on CV outcomes and mortality if started within 10 days from occurrence of an AMI.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p15-17 | DOI: 10.33696/diabetes.6.058
Semaglutide for Treatment of Obesity-Related Heart Failure with Preserved Ejection Fraction in Patients with and without Diabetes
Nasser Mikhail , Soma Wali
The glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide is effective for the treatment of obesity and type 2 diabetes mellitus (T2DM). The purpose of this article is to define the therapeutic role of semaglutide for obesity-related heart failure with preserved ejection fraction (HF-pEF). Methods: Critical review of 2 recent randomized trials, the Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF) and STEP-HFpEF DM.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p18-23 | DOI: 10.33696/diabetes.6.059
Lifestyle Modification Practice and Associated Factors among Type 2 Diabetic Patients in Oromia: A Multicenter Study
Dursa Hussein , Tinsae Abeya Geleta , Amanuel Girma , Tadesse Bekele , Derara Girma , Seifu Mohammed Ibrahim , Meron Seyoum Lakew , Bedo Megersa Kumbe , Befekadu Tesfaye Oyato
Diabetes mellitus is a metabolic disorder characterized by high blood glucose levels due to insulin irregularities. It is frequently accompanied by difficulties in the metabolism of carbohydrates, fats, and proteins. Despite the significant loss of life and resources associated with DM, management remains insufficient. This management typically involves pharmacologic interventions and lifestyle modifications (LSM). However, a majority of patients and caregivers tend to disregard LSM in the management of type 2 diabetic patients.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p24-34 | DOI: 10.33696/diabetes.6.060
Epac1 Regulates Ephb1/Ephrin B1 in Retinal Müller Cells
Li Liu , Youde Jiang , Jena J. Steinle
Eph B1/Ephrin B1 signaling has been shown to play a role in inflammation and pain in some targets; however, its upstream regulation is less clear. To investigate whether exchange protein for cAMP1 (Epac1) can regulate EphB1/ephrin B1 in retinal Müller cells, we generated Epac1-Müller cell specific knockout mice. We used protein analyses to show that Epac1 regulates both EphB1/ephrin B1, as well as high mobility group box 1 (HMGB1) and NLR family pyrin domain containing 3 (NLRP3).
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p35-39 | DOI: 10.33696/diabetes.6.061
Comorbidity of Hyperglycemia and Dyslipidemia among Factory Workers: A Study on the Interrelationship of Metabolic Disorders in Occupational Settings
Benjamin Tetteh Mensah , Dorinda Naa Okailey Armah , Jemima Okyere , Lawrence Annison , Samuel Antwi-Baffour
Hyperglycemia, characterized by elevated blood glucose levels, often leads to diabetes mellitus and severe complications if unmanaged. Globally, hyperglycemia is a pressing public health issue, exacerbated by increasing diabetes prevalence. In sub-Saharan Africa, including Ghana, the rise in diabetes cases is alarming, necessitating urgent health interventions. Concurrently, dyslipidemia, marked by abnormal lipid levels, contributes significantly to cardiovascular diseases. This study aims to investigate the comorbidity of hyperglycemia and dyslipidemia among factory workers in an urban center in Ghana, providing insights into this high-risk group's health status.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p40-47 | DOI: 10.33696/diabetes.6.062
Incidence of Diabetic Mellitus among HIV Patients Receiving Antiretroviral Therapy in Ethiopia: Ten Years Retrospective Follow-up Study
Lidiya Tekle Gebreyohannes , Addisu Dabi Wake
Diabetes mellitus (DM) is an important chronic comorbid condition that occurs in people living with the human immunodeficiency virus (HIV). It is associated with increased morbidity and mortality. Many cases of comorbidities with diabetes mellitus have been reported, particularly in areas of the world where the prevalence of HIV is high. The rate of diabetes hospitalizations among HIV-infected individuals increased from 3.9 to 8.4 per 100 hospitalizations. Although the cost of HIV care has increased, the burden of DM among people living with HIV has economic consequences.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p48-55 | DOI: 10.33696/diabetes.6.063
Effect of UV Photo Functionalization on the Antimicrobial Properties of Implants in Patients with Type 2 Diabetes Mellitus
Hakob Khachatryan , Lazar Yessayan , Gagik Hakobyan
The purpose of this study is to evaluate the effect of ultraviolet UV photo functionalization on the antimicrobial properties in implants installed in patients with type 2 diabetes mellitus. The study included 74 patients with diabetes with unilateral/bilateral missing teeth (aged 36 to 63 years). The participants were randomly divided into 2 groups; Group-A included 38 patients with UV photo functionalized 204 implants and Group-B included 36 patients with non UV photo functionalized 183 implants.
J Diabetes Clin Res, 2024, Volume 6, Issue 1, p56-64 | DOI: 10.33696/diabetes.6.064